Drug Profile
Monoclonal antibody C5
Alternative Names: Anti-TAA humanised antibody C5Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Center of Molecular Immunology
- Class Antirheumatics; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Cuba (Parenteral)
- 28 Mar 2003 Preclinical trials in Cancer in Cuba (parenteral)